Industry Odisha Bureau, Jul 26: India currently faces a complex trade environment characterized by shifting tariff policies and geopolitical uncertainties. The 10 percent U.S. tariff rate applied to Indian exports reflects both a diplomatic outcome and an ongoing pattern of tariff volatility. This rate followed a February Supreme Court decision that invalidated previous tariff frameworks, after which India was initially proposed a higher 12.5 percent rate. The proposal for 200 percent tariffs on generic pharmaceuticals, positioned as a two-year negotiating mechanism, illustrates how tariff announcements function as policy instruments in broader trade discussions.
Several structural vulnerabilities characterize India’s current export position. The concentration of exports toward American markets creates exposure to policy shifts, while simultaneous pressures from geopolitical instability in West Asia and global trade fragmentation compound existing challenges. These factors intersect to create multiple demand uncertainties across traditional export corridors.
India has implemented several policy responses to address these vulnerabilities. Free Trade Agreements across Asia, Southeast Asia, and Africa provide alternative export pathways. The Production Linked Incentive scheme and Make in India programme target domestic manufacturing capacity expansion. Infrastructure initiatives including the National Logistics Policy and PM Gati Shakti aim to enhance export competitiveness. These measures represent foundational steps that require both implementation refinement and strategic deepening.
A comprehensive approach to enhancing export resilience involves multiple interconnected elements. FTA networks require stronger implementation frameworks to translate negotiated agreements into measurable export growth through improved supply-chain integration and business engagement. Trade negotiation capacity needs strengthening via enhanced expertise and institutional resources. Investment in high-value manufacturing sectors semiconductors, advanced electronics, and specialized pharmaceuticals could reduce import dependence while preserving integration within global value chains.
Complementary measures include accelerating port modernization, streamlining regulatory processes for exporters, and expanding export credit facilities. Improved coordination between central and state governments on trade objectives could identify competitive advantages. Enhanced support for micro, small, and medium enterprises seeking export market access would broaden participation in trade activities.
The pharmaceutical sector exemplifies both current vulnerabilities and potential opportunities. India’s substantial generic drug exports to the United States face tariff exposure, yet targeted research and development investments could shift production toward higher-value products with reduced tariff sensitivity.
Building a more resilient export base requires sustained institutional commitment and strategic continuity. This multifaceted approach emphasizes diversification, technological sophistication, and structural vulnerability reduction rather than reactive responses to individual policy announcements.
